SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-23-012221
Filing Date
2023-09-08
Accepted
2023-09-08 17:03:47
Documents
1
Period of Report
2023-08-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-62532.html 4  
1 PRIMARY DOCUMENT marketforms-62532.xml 4 20678
  Complete submission text file 0001214659-23-012221.txt   22030
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Issuer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2525 WEST END AVENUE, SUITE 950 NASHVILLE TN 37203
Business Address
Young Caroline (Reporting) CIK: 0001684087 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33637 | Film No.: 231246013